| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |